WTH? “Vaccine” Medical Poisons Can Now Be Delivered via Ultrasound
Public willingness to get injected with who-knows-what from vaccine needles is waning. Thus, scientists are now developing needleless vaccines that they claim can be delivered to a person’s body through ultrasound.
At the recent Acoustics 2023 event in Sydney, scientists unveiled the concept along with a press release from the Acoustical Society of America (ASA), which co-hosted the event along with the Australian Acoustical Society.
“The scientific conference brings together acousticians, researchers, musicians and more experts from around the world,” the press release reads.
“While in Sydney, they will describe their work on various topics including needle-free ultrasound-enhanced vaccine delivery, automated pop song mashups, impacts of acoustic design in prisons and auditory sensory augmentation to support table tennis games for people with vision loss.”
Darcy Dunn-Lawless, a doctoral student at the University of Oxford‘s Institute of Biomedical Engineering, presented his team’s findings – the findings that were revealed at the conference – in a paper that provides an overview of the experiment and how it could change the way vaccines are delivered.
(Related: Check out our earlier report on the needleless vaccines that the National Institutes of Health [NIH] is developing in partnership with billionaire eugenicist Bill Gates.)
Prepare to get “jabbed” through your skin
For their experiment, Dunn-Lawless and his colleagues conducted in vivo (in a living organism) tests that they say produced a greater immune response than conventional injections, but with 700 times fewer vaccine molecules.
In other words, a whole lot less vaccine material is needed using the ultrasound delivery route rather than the injection delivery route – and the effects, we are told, are much greater with ultrasound.
Known as the cavitation approach, the ultrasound model of vaccine delivery is believed to be more effective than injection delivery due in part to the immune-rich skin on which the ultrasound works.
Instead of injecting vaccine material into muscle tissue as has long been the norm, the ultrasound vaccination method uses the skin to deliver vaccine doses without a needle.
Based on the experiments already conducted, ultrasound vaccination is cheaper for Big Pharma to produce and supposedly safer than injectable vaccines.
Dunn-Lawless works as part of a larger team under the supervision of Dr. Mike Gray, Prof. Bob Carlisle and Prof. Constantin Coussios, all within Oxford’s Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals Laboratory (BUBBL).
“Their cavitation approach may be particularly conducing to DNA vaccines that are currently difficult to deliver,” reports Wine Press News.
“With cavitation able to help crack open the membranes blocking therapeutic access to the cell nucleus, the other advantages of DNA vaccines, like a focused immune response, low infection risk and shelf stability, can be better utilized.”
In a statement, Dunn-Lawless explained how an acoustic effect called “cavitation,” hence the name of the technology, involves the “popping of bubbles in response to a sound wave.”
“We aim to harness the concentrated bursts of mechanical energy produced by these bubble collapses in three main ways,” Dunn-Lawless says.
“First, to clear passages through the outer layer of dead skin cells and allow vaccine molecules to pass through. Second, to act as a pump that drives the drug molecules into these passages. Last, to open up the membranes surrounding the cells themselves, since some types of vaccine must get inside a cell to function.”
Dunn-Lawless says the only real side effect, which he says is universal to all physical techniques in medicine, is if a practitioner applies to much energy to the patient’s body, leaving behind damaged tissue.
“Exposure to excessive cavitation can cause mechanical damage to cells and structures,” he admits.
“However, there is good evidence that such damage can be avoided by limiting exposure, so a key part of my research is to try and fully identify where this safety threshold lies for vaccine delivery.”
